ICE Rolls Out Encompass-Integrated Fraud Monitor Solution
ICE launches an Encompass-integrated Fraud Monitor, centralizing fraud risk signals and property data. Early pilots i...
Which Has Lower Fees Index Fund Or Target Date Retirement
Compare which has lower fees between index funds and target date retirement options to understand true costs and impact on returns. Make smarter retirement choices with clear, practical guidance.
28,228 articles
Honda Recalls 880,000 Vehicles Over Rear Suspension Issue
Honda Motor Co. announced a nationwide recall covering about 880,000 vehicles due to a suspected rear suspension prob...
Year Study Shows Which CEOs Back RTO Push: A Six-Year Look
A six-year analysis ties CEO ego cues to push for in-person work, highlighting how office-first power dynamics influe...
Can $10,000? Broadcom Marvell: Only One Matches AI Hype
Broadcom and Marvell delivered AI-fueled earnings, but the race to sustain AI momentum hinges on scale, software, and...
Best Aerospace and Defense Stocks to Watch in 2026
As defense budgets stay elevated and geopolitical tensions linger, investors are targeting the best aerospace and def...
Circle Stock Jumped February: What Sparked the Rally
Circle stock jumped february as investors weighed an earnings beat against a choppy crypto backdrop. This article unp...
Cramer: Marvell Beat Sales Signals Data Center Play
Jim Cramer spotlights a surprising quarter from Marvell, arguing the company’s data center-focused growth could redef...
Pfizer's 6.5% Dividend Yield: Skepticism Silenced Now
A high dividend can spark doubt. This article breaks down pfizer's 6.5% dividend yield, what it signals about the bus...
California’s Mandatory Worldwide Combined Policy: A Mistake
California weighs a sweeping tax rule that would tax global income of multinationals. This piece explains why the ide...
FIFA’s Foray Into Dynamic Pricing Sparks Backlash Among Fans
State investigators are scrutinizing FIFA ticketing as dynamic pricing drives eye-popping costs and questions about s...
Lilly Novo Nordisk Battle Intensifies as Obesity Drugs Surge
Eli Lilly's Q1 2026 results slam the lid on the GLP-1 duopoly's early calm, with Lilly’s revenue exploding and Novo N...
Analyst Just Declared Lilly the Clear Winner at ADA Conference
The ADA conference spotlighted Lilly and Novo Nordisk in the GLP-1 race. This deep dive explains what the claims mean...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status